NCT00089440Unknown1 期
Assessment of Interactions Between IV Methamphetamine and Aripiprazole
适应症
相关药物
试验速览
- 阶段
- 1 期
- 入组人数
- 17
- 试验地点
- 2
- 主要终点
- Adverse effect measures
研究概览
简要总结
The purpose of this study is to assess the interactions between intravenous methamphetamine and aripiprazole.
详细描述
This is a double-blind, placebo-controlled human laboratory clinical pharmacology study to assess potential interactions between intravenous d-methamphetamine infusion and treatment with oral aripiprazole.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Must meet DSM-4 criteria for methamphetamine abuse or dependence and are non-treatment seeking.
- •Ability to verbalize understanding of the consent form, able to provide written informed consent, and verbalize willingness to complete study procedures.
排除标准
- •Please contact the site for more information.
结局指标
主要结局
Adverse effect measures
pharmacokinetic assessment
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
1 期
Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1Amphetamine-Related DisordersNCT00033072National Institute on Drug Abuse (NIDA)16
Unknown
1 期
A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1Amphetamine-Related DisordersNCT00267657National Institute on Drug Abuse (NIDA)30
Unknown
1 期
Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1Amphetamine-Related DisordersNCT00265278National Institute on Drug Abuse (NIDA)16
Unknown
1 期
Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1Amphetamine-Related DisordersNCT00040040National Institute on Drug Abuse (NIDA)20
已完成
不适用
Interactions between 3,4-methylenedioxymethamphetamine (MDMA or ’ecstasy’) and Ä9-tetrahydrocannabinol (THC or ‘marihuana’) in humansMDMA and THC (co-) exposureNL-OMON27417ZonMw16